- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IDEXX Laboratories Inc (IDXX)
IDEXX Laboratories Inc stock price live, this page displays NASDAQ IDXX stock exchange data. View the IDXX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IDEXX Laboratories Inc real time stock price chart below.
What Is the IDEXX Laboratories Inc Stock Price Today?
The IDEXX Laboratories Inc stock price today is 545.56.
What Is the Stock Symbol for IDEXX Laboratories Inc?
The stock symbol for IDEXX Laboratories Inc is "IDXX."
What Stock Exchange Does IDEXX Laboratories Inc Trade On?
IDEXX Laboratories Inc is listed and trades on the NASDAQ stock exchange.
Is IDEXX Laboratories Inc a Good Stock to Buy?
Determining whether IDEXX Laboratories Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IDXX quote. (ISIN: US45168D1046)
What Is the IDEXX Laboratories Inc Stock Price Today?
The IDEXX Laboratories Inc stock price today is 545.56.
What Is the Stock Symbol for IDEXX Laboratories Inc?
The stock symbol for IDEXX Laboratories Inc is "IDXX."
What Stock Exchange Does IDEXX Laboratories Inc Trade On?
IDEXX Laboratories Inc is listed and trades on the NASDAQ stock exchange.
Is IDEXX Laboratories Inc a Good Stock to Buy?
Determining whether IDEXX Laboratories Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IDXX quote. (ISIN: US45168D1046)
Currency in USD
545.56
-1.45(-0.27%)
Closed·
Pre Market
545.59+0.03(+0.01%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
540.68
549.52
52 wk Range
356.14
549.52
IDXX Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
540.68549.52
52 wk Range
356.14549.52
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IDXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
518.46
Downside
-4.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
IDEXX Labs Company Profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDEXX Laboratories Inc SWOT Analysis
Market Leadership | Explore IDEXX's dominance in veterinary diagnostics, balancing declining visits with increased utilization and innovative product launches |
Financial Resilience | Despite market headwinds, IDEXX maintains robust profitability with a 60.7% gross margin and 7.2% revenue growth, showcasing its financial strength |
Growth Projections | Analysts forecast sustainable double-digit top-line growth for IDEXX, with price targets ranging from $481 to $630, reflecting optimistic long-term outlook |
Strategic Innovation | Delve into IDEXX's product development strategy, including the inVue Dx Analyzer and IDXX Cancer Dx, driving competitive advantage in a evolving market |
IDEXX Laboratories Inc Earnings Call Summary for Q1/2025
- Q1 2025 EPS of $2.96 beat forecast by $0.10; revenue slightly missed at $998.43M; stock surged 9.92% post-announcement
- 5% organic revenue growth driven by new product launches; gross margin up 80 basis points to 62.4%
- Full-year EPS guidance updated to $11.93-$12.43; plans to expand IDEXX InVue DX placements to over 4,500 units in 2025
- CEO emphasized early cancer detection importance; CFO noted guidance range reflects expected outcomes
- Challenges include supply chain issues, declining U.S. clinical visits, and macroeconomic pressures in veterinary industry
Last Updated: 01-05-2025, 07:16 pm
Read Full TranscriptCompare IDXX to Peers and Sector
Metrics to compare | IDXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIDXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 49.0x | −3.0x | −0.5x | |
PEG Ratio | 10.22 | 0.08 | 0.00 | |
Price/Book | 30.3x | 2.4x | 2.6x | |
Price / LTM Sales | 11.2x | 3.8x | 3.0x | |
Upside (Analyst Target) | −1.0% | 30.7% | 49.2% | |
Fair Value Upside | Unlock | 8.9% | 7.4% | Unlock |
Analyst Ratings
7 Buy
6 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 518.46
(-4.97% Downside)
Earnings
Latest Release
May 01, 2025
EPS / Forecast
2.91 / 2.86
Revenue / Forecast
998.43M / 1.00B
FAQ
What Is the IDEXX Labs (IDXX) Stock Price Today?
The IDEXX Labs stock price today is 545.56.
What Stock Exchange Does IDEXX Labs Trade On?
IDEXX Labs is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for IDEXX Labs?
The stock symbol for IDEXX Labs is "IDXX."
What Is the IDEXX Labs Market Cap?
As of today, IDEXX Labs market cap is 43.87B.
What Is IDEXX Labs's Earnings Per Share (TTM)?
The IDEXX Labs EPS (TTM) is 10.91.
When Is the Next IDEXX Labs Earnings Date?
IDEXX Labs will release its next earnings report on 03 Aug 2025.
From a Technical Analysis Perspective, Is IDXX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has IDEXX Labs Stock Split?
IDEXX Labs has split 4 times.
How Many Employees Does IDEXX Labs Have?
IDEXX Labs has 11000 employees.
What is the current trading status of IDEXX Labs (IDXX)?
As of 08 Jul 2025, IDEXX Labs (IDXX) is trading at a price of 545.56, with a previous close of 545.56. The stock has fluctuated within a day range of 540.68 to 549.52, while its 52-week range spans from 356.14 to 549.52.
What Is IDEXX Labs (IDXX) Price Target According to Analysts?
The average 12-month price target for IDEXX Labs is USD518.45538, with a high estimate of USD625 and a low estimate of USD385. 7 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -4.97% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.